Business

Challenges to a Company’s Psilocybin Patent Highlight Contrasting Business Strategies for Developers of Psychedelic Therapies

Tactics used by Compass Pathways common to pharma companies pose ethical questions for the emerging psychedelics industry. Part one of a three-part series.

Support Psychedelic Journalism
Mission